| Premiums and fees | |
| Net investment income | 282M |
| Mail order pharmacy revenues | 762M |
| Other revenues | 1.16B |
| Other-than-temporary impairments on debt securities, net | -1M |
| Other realized investment gains | 76M |
| Total realized investment gains before income taxes | |
| Total revenues | 9.88B |
| Health Care medical claims expense | 4.69B |
| Other benefit expenses | 1.34B |
| Mail order pharmacy cost of goods sold | 638M |
| GMIB fair value loss | |
| Other operating expenses | |
| Total benefits and expenses | 9.14B |
| Income before Income Taxes | |
| Current | 210M |
| Deferred | 80M |
| Total taxes | 290M |
| Net Income | 452M |
| Less: Net Income Attributable to Noncontrolling Interest | -4M |
| Shareholders' Net Income | |
| Shareholders' net income | 1.78 |
| Shareholders' net income | 1.76 |
| Dividends Declared Per Share | 0 |